In a rising cost environment, it is critical for businesses to have real-time visibility as to precisely how higher consumer prices and cost containment practices are impacting EBITDA.

A new private equity (PE) platform was built from 15 add-on acquisitions to achieve revenue synergies across the entities.

In this article we take a look at the importance of a continued commitment to determining impairments, despite the rebound in both equity and debt markets, as well as recommended best practices in both enterprise valuation and portfolio review during the ongoing pandemic.